Gene · 1272
CNTN1: contactin 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CNTN1: contactin 1. Genes, record 1272. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1272
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q12860 | Contactin-1 | 1,018 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents39
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 42184 | Q12860 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 42190 | Q12860 | Espacenet |
| WO 2025259600 A2 | 2025-12-18 | 28 | Q12860 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 5619 | Q12860 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 5261 | Q12860 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 3126 | Q12860 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 3127 | Q12860 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 5922 | Q12860 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 5922 | Q12860 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 5261 | Q12860 | Espacenet |
1 to 10 of 39
See all 39 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants940
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CNTN1 papers | Newest fiscal year |
|---|---|---|---|
| ZIAHL006001 | Framingham Project/Levy | 6 | 2025 |
| P30DK040561 | Boston Area Nutrition Obesity Research Center (NORC) | 5 | 2025 |
| R01DK064380 | Molecular Mechanisms Regulating Epithelial Cell Apical Polarity and Ciliogenesis | 5 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 3 | 2025 |
| P30AG062715 | Wisconsin Alzheimer's Disease Research Center | 2 | 2025 |
| P30AG066507 | Johns Hopkins Alzheimer's Disease Research Center | 2 | 2025 |
| P30AR069589 | Penn Skin Biology and Diseases Resource-based Center | 2 | 2025 |
| P30CA043703 | Case Comprehensive Cancer Center Support Grant | 2 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 2 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 2 | 2025 |
1 to 10 of 940Source NIH's project files
See all 940 nih grantsPapers1,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-Contactin-1-Associated Membranous Nephropathy Presenting With Subsequent Autoimmune Nodopathy. | Kidney Med | 2026 | 42787889 | PubTator, text mining | PubMed |
| The clinical features of anti-CNTN1 antibodies associated autoimmune nodopathies with nephropathy: a case series. | Front Neurol | 2026 | 42755838 | PubTator, text mining | PubMed |
| Pathophysiology and Emerging Therapies in Chronic Inflammation Demyelinating Polyneuropathy. | Intern Med | 2026 | 42749655 | PubTator, text mining | PubMed |
| Beyond Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Anti-Contactin-1 Autoimmune Nodopathy Unmasked by Proteinuria. | J Clin Med | 2026 | 42652648 | PubTator, text mining | PubMed |
| Anti-Contactin-1 Nodopathy Presenting With Dysphagia and Nephrotic Syndrome: Remarkable Neurological and Renal Recovery Following Early B-Cell-Targeted Therapy. | Neurologist | 2026 | 42594268 | PubTator, text mining | PubMed |
| Neuro-renal syndrome (NRS) in autoimmune nodopathies and paranodopathies: A warning to consider the diagnosis when anti-node and paranode antibody tests are difficult to perform. | J Neurol Sci | 2026 | 42497634 | PubTator, text mining | PubMed |
| Autoimmune nodopathies: a clinical review. | Clin Neurophysiol | 2026 | 42492459 | PubTator, text mining | PubMed |
| CNTN-1 regulates malignant biological behaviors of lung squamous cell carcinoma (LUSC) via the endoplasmic reticulum stress (ERS)/epithelial-mesenchymal transition (EMT) axis. | Transl Cancer Res | 2026 | 42445425 | PubTator, text mining | PubMed |
| Mining biomarkers for type 2 diabetic nephropathy based on urinary proteomics and metabolomics. | Front Endocrinol (Lausanne) | 2026 | 42440498 | PubTator, text mining | PubMed |
| Development and Inter-Laboratory Validation of Multiplex Flow Cytometry Assay for Autoimmune Nodopathy. | J Peripher Nerv Syst | 2026 | 42437960 | PubTator, text mining | PubMed |
1 to 10 of 1,322
See all 1,322 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1272
GET https://conductscience.org/api/genes/v1/1272/patents?page=2